openPR Logo
Press release

Inhalation Anesthesia Market on the Rise with Advancements in Technology and Growing Demand for Surgeries

10-07-2024 02:32 PM CET | Health & Medicine

Press release from: Emergen Research

Inhalation Anesthesia Market

Inhalation Anesthesia Market

The global inhalation anesthesia arket size was USD 1.43 Billion in 2022 and is expected to register a rapid revenue CAGR of 9.5% during the forecast period. The global inhalation anesthesia market is experiencing significant growth, driven by technological advancements, the increasing prevalence of chronic diseases, and a rising global demand for surgeries. The market is set to expand further with innovations in anesthesia delivery systems and growing awareness of eco-friendly practices.

Download Free Exclusive Sample PDF@ https://www.emergenresearch.com/request-sample/2848

Key Drivers of Growth:

The market is propelled by advancements in closed-loop anesthesia delivery systems, which utilize real-time data to automatically adjust anesthetic drug delivery. These technologies, including brain function monitoring and artificial intelligence (AI) integration, are enhancing the precision of anesthesia, reducing the risks of over- or under-dosing, and improving patient outcomes.

Additionally, the rise in chronic diseases, which affect individuals globally, has contributed to an increased need for surgeries, thus boosting the demand for inhalation anesthetics. According to the World Health Organization (WHO), chronic diseases like heart disease, cancer, and diabetes account for 71% of global deaths, which in turn drives the need for anesthesia in surgical interventions.

The aging population also plays a pivotal role in market expansion. As life expectancy increases, the elderly are more susceptible to age-related conditions that require surgical treatment, further fueling the demand for inhalation anesthetics. Minimally invasive and robotic surgery techniques are also gaining traction, as they offer benefits such as faster recovery and reduced complications.

Technological advancements are reshaping the market as well. For example, the introduction of gas recapture technology by Baxter in collaboration with ZeoSys reduces environmental impact and enhances hospital efficiency by safely storing and processing anesthetic gases.

Challenges Facing the Market:

However, the market is not without its challenges. Side effects associated with inhalation anesthesia drugs, including nausea and vomiting, present a significant restraint on market growth. These side effects vary from patient to patient, and long-term exposure to anesthetics could potentially lead to more serious complications. Despite these concerns, most side effects are temporary, and efforts are underway to minimize them while ensuring effective pain relief.

Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/2848

Product Segment Insights:

The inhalation anesthesia market is segmented into products such as desflurane, isoflurane, and sevoflurane. Among these, sevoflurane holds the largest market share. Its quick onset, rapid recovery, and minimal impact on heart rate and blood pressure make it particularly appealing for pediatric and cardiovascular surgeries.

The isoflurane segment is also expected to witness steady growth, driven by its cost-effectiveness and use in muscle relaxation during certain surgeries. Isoflurane's affordability makes it an attractive choice for healthcare facilities looking to manage costs without compromising on safety or efficacy.

Application and End-Use Insights:

In terms of application, the maintenance segment is expected to dominate the market, fueled by advancements in technology that allow for precise control during surgeries. Newer anesthetics with longer durations of action reduce the need for frequent adjustments, streamlining workflows and enhancing efficiency in operating rooms.

The induction segment is set to grow moderately, with the increasing demand for minimally invasive procedures that require fast-acting anesthesia. This segment is particularly important for surgeries that prioritize early recovery and minimal post-operative complications.

On the basis of end-use, hospitals are anticipated to maintain the largest share of the market, as they are the primary settings for the majority of surgical procedures. Hospitals benefit from advanced infrastructure, cutting-edge technology, and established systems for managing the supply and distribution of anesthetics, giving them a competitive advantage over smaller healthcare facilities.

Acquire the complete research report on the Global Market@ https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market

Inhalation Anesthesia Top Companies and Competitive Landscape

The global inhalation anesthesia market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective inhalation anesthesia solutions.

Some major players included in the global inhalation anesthesia market report is:

Baxter

AbbVie Inc.

Piramal Enterprises Ltd.

Sandoz Group AG

Fresenius Kabi AG

Abbott

Halocarbon, LLC

Hikma Pharmaceuticals PLC.

Eisai Co., Ltd

Novartis AG

Inhalation Anesthesia Latest Industry Updates

On 10 January 2022, Dechra announced to acquire Isoflurane and Sevoflurane, two key inhalation anesthetics, from Halocarbon Life Sciences. Dechra's acquisition enhances its anesthesia portfolio, providing vets with more choices for safe and effective pain management during procedures. Isoflurane and sevoflurane seamlessly complement Dechra's existing offerings in sedation and anesthesia, creating a comprehensive solution for vet clinics. This acquisition marks a positive step for Dechra, further strengthening its position in the veterinary market and potentially improving the quality of care.

Make Payment [Buy your Exclusive copy] @ https://www.emergenresearch.com/select-license/2848

For the purpose of this report, Emergen Research has segmented the global Inhalation anesthesia market on the basis of product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2019-2032)

Desflurane

Isoflurane

Sevoflurane

Application Outlook (Revenue, USD Billion; 2019-2032)

Induction

Maintenance

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospital

Ambulatory Surgical Center (ASC)

Others

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Benelux

Russia

Rest of Europe

Asia Pacific

China

Japan

South Korea

India

ASEAN Countries

Oceania

Rest of APAC

Latin America

Brazil

Mexico

Rest of LATAM

Middle East & Africa

GCC Countries

Israel

Turkey

South Africa

Rest of Middle East & Africa

Look Over transcripts provided by Emergen Research

Inhalation Anesthesia Market Size@ https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market/market-size

Inhalation Anesthesia Market Share@ https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market/market-share

Inhalation Anesthesia Market Trends@ https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market/market-trends

Inhalation Anesthesia Regional Market Demand@ https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market/regional-market-demand

Inhalation Anesthesia Market Analysis@ https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market/market-analysis

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inhalation Anesthesia Market on the Rise with Advancements in Technology and Growing Demand for Surgeries here

News-ID: 3680512 • Views:

More Releases from Emergen Research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion in 2023, Set for Strong Growth at 16.5% CAGR
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems. The market is also benefiting from the
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13.6% CAGR
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions. Stem cell therapies offer the ability to repair, replace, or restore damaged tissues
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophisticated
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing at 13.9% CAGR
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia. Once seen as

All 5 Releases


More Releases for Inhalation

Transformative Trends Impacting the Inhalation Anesthesia Market Landscape: Seda …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Inhalation Anesthesia Market Size By 2025? The market for inhalation anesthesia has been experiencing significant growth in the past few years. The market is expected to expand from $1.54 billion in 2024 to $1.65 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.9%. Several factors have contributed
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
Emerging Trends Influencing The Growth Of The Inhalation Anesthesia Market:Sedac …
The Inhalation Anesthesia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Inhalation Anesthesia Market Size Expected to Be by 2034? In recent years, the size of the inhalation anesthesia market has experienced significant growth. Forecasts predict growth from $1.54 billion in 2024
Key Trends Shaping the Future Inhalation Sedatives Market From 2025-2034: Challe …
What Is the Estimated Market Size and Growth Rate for the Inhalation Sedatives Market? Over recent years, there has been a consistent expansion in the market for inhalation sedatives. Forecasted growth from 2024's $2.24 billion to $2.34 billion in 2025 indicates a compound annual growth rate (CAGR) of 4.2%. The augmenting occurrence of chronic illnesses, an ever-growing elderly population, heightened consciousness about inhalation sedatives along with escalating investment in exploration and
Key Trends Shaping the Future Inhalation Sedatives Market From 2025-2034: Challe …
What Is the Estimated Market Size and Growth Rate for the Inhalation Sedatives Market? Over recent years, there has been a consistent expansion in the market for inhalation sedatives. Forecasted growth from 2024's $2.24 billion to $2.34 billion in 2025 indicates a compound annual growth rate (CAGR) of 4.2%. The augmenting occurrence of chronic illnesses, an ever-growing elderly population, heightened consciousness about inhalation sedatives along with escalating investment in exploration and
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of